What Doctors Don't Tell YouAnother anti-inflammatory bites the dust. Another COX-2 inhibitor has been shot down by the FDA. Having spent the last two months reviewing the safety of the COX-2-selective non-steroidal anti-inflammatory drugs (NSAIDs), the US regulatory agency...
A new trial has shown that warfarin or warfarin plus aspirin are 20 to 30 per cent better than aspirin alone in preventing composite vascular events after myocardial infarction (MI).
